Key facts
- This page summarizes Robert Profusek's Form 4 filing for Kodiak Sciences Inc. (KOD).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 02 Jul 2025, 16:48.
Robert Profusek - 30 Jun 2025 Form 4 Insider Report for Kodiak Sciences Inc. (KOD)
- Role
- Director
- Signature
- /s/ David Peinsipp, Attorney-in-Fact for Robert Profusek
- Issuer symbol
- KOD
- Transactions as of
- 30 Jun 2025
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 02 Jul 2025, 16:48:57 UTC
- Previous filing
- 08 Nov 2024
- Next filing
- 10 Nov 2025
- SEC
- View on sec.gov
Key filing fact
Robert Profusek filed Form 4 for Kodiak Sciences Inc. (KOD) on 02 Jul 2025.
Change
- Previous filing in this sequence was filed on 08 Nov 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001143732
Primary reporting owner
PROFUSEK ROBERT
- Relationship
- Director
- Address
- 1250 PAGE MILL ROAD, PALO ALTO
- Signature
- /s/ David Peinsipp, Attorney-in-Fact for Robert Profusek
- Signature date
- 02 Jul 2025
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
KOD
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +40,000
- Change %
- Price
- $0.000000
- Shares after
- 40,000
- Date
- 30 Jun 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,000
- Exercise price
- $3.73
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 30, 2026 or one (1) day prior to the Issuer's next annual meeting occurring after the grant date, in each case, provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date. |